Literature DB >> 21347995

Chemical constituents and pharmacological properties of Poria cocos.

José-Luis Ríos1.   

Abstract

Poria cocos (Polyporaceae) is a saprophytic fungus that grows in diverse species of Pinus. Its sclerotium, called fu-ling or hoelen, is used in traditional Chinese and Japanese medicine for its diuretic, sedative, and tonic effects. Various studies of this fungus have demonstrated its marked anti-inflammatory activity in different experimental models of acute and chronic inflammation. It is widely used as a constituent of many preparations in Asian medicine, but the number of research papers on its clinical properties is insufficient for establishing its efficacy and safety from a scientific point of view. In this review, we have compiled all the published data concerning the chemistry, pharmacology, and clinical uses of this drug in order to evaluate its clinical interest for future use against various pathologies in which inflammation and immunodepression are implicated. We selected the papers for review on the basis of their ethnopharmacological relevance, using the most relevant databases for the biomedical sciences. Studies on various fungus extracts as well as on the major phytochemical compounds (polysaccharides and triterpenoids) present in Poria cocos comprised the principal objectives of this review. In several of the studies reviewed, the inhibitory effects of triterpenes on phospholipase A (2) (PLA (2)) have been clearly demonstrated. In addition, the inhibitory effects of Poria cocoson the secretion of different cytokines from human peripheral blood monocytes have also been described. Triterpenoids are known to have a pivotal influence on certain diseases such as rheumatoid arthritis, psoriasis, autoimmune uveitis, septic shock, and possibly bronchial asthma, while polysaccharides can potentiate the immune response. Reviewing the literature, we found that polysaccharides from Poria cocos enhanced the secretion of immune stimulators and suppressed the secretion of immune suppressors, thus potentiating the immune response. In addition, they showed antitumor activity against different cancer cell lines. This activity is associated with their capacity to inhibit angiogenesis by downregulating both NF- κB and the induction of NF- κB/Rel translocation. © Georg Thieme Verlag KG Stuttgart · New York.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21347995     DOI: 10.1055/s-0030-1270823

Source DB:  PubMed          Journal:  Planta Med        ISSN: 0032-0943            Impact factor:   3.352


  69 in total

1.  Development of crossbreeding high-yield-potential strains for commercial cultivation in the medicinal mushroom Wolfiporia cocos (Higher Basidiomycetes).

Authors:  Xiaozhao Xiang; Xiaoxia Wang; Yinbing Bian; Zhangyi Xu
Journal:  J Nat Med       Date:  2016-04-21       Impact factor: 2.343

2.  Effect of Poria cocos hydroethanolic extract on treating adriamycin-induced rat model of nephrotic syndrome.

Authors:  Jun-Feng Zan; Chan-Juan Shen; Li-Ping Zhang; Yan-Wen Liu
Journal:  Chin J Integr Med       Date:  2016-12-29       Impact factor: 1.978

3.  Randomized, double-blind, placebo-controlled superiority trial of the Yiqigubiao pill for the treatment of patients with chronic obstructive pulmonary disease at a stable stage.

Authors:  Feng-Sen Li; Yan-Li Zhang; Zheng Li; Dan Xu; Chun-Yan Liao; Huan Ma; Li Gong; Jun Su; Qi Sun; Qian Xu; Zhen Gao; Ling Wang; Jing Jing; Jing Wang; Min Jiang; Ge Tian; Bilal Hasan
Journal:  Exp Ther Med       Date:  2016-09-06       Impact factor: 2.447

4.  The Phosphatome of Medicinal and Edible Fungus Wolfiporia cocos.

Authors:  Wenjun Zhu; Wei Wei; Shaopeng Zhang; Yonglian Zheng; Ping Chen; Xiaowen Xu
Journal:  Curr Microbiol       Date:  2017-09-12       Impact factor: 2.188

5.  Chemical constituents from Inonotus obliquus and their antitumor activities.

Authors:  Fenqin Zhao; Guiyang Xia; Lixia Chen; Junli Zhao; Zhanfang Xie; Feng Qiu; Guang Han
Journal:  J Nat Med       Date:  2016-05-14       Impact factor: 2.343

6.  Anticancer effect of fermented Insampaedok-san in human colon cancer cells: a pilot study.

Authors:  Hwayong Park; Kwang Dong Kim
Journal:  Mol Biol Rep       Date:  2018-04-02       Impact factor: 2.316

7.  Poria cocos Modulates Th1/Th2 Response and Attenuates Airway Inflammation in an Ovalbumin-Sensitized Mouse Allergic Asthma Model.

Authors:  Chien-Liang Chao; Chao-Jih Wang; Hsin-Wen Huang; Han-Peng Kuo; Muh-Hwan Su; Hang-Ching Lin; Chia-Wen Teng; Leticia B Sy; Wen-Mein Wu
Journal:  Life (Basel)       Date:  2021-04-21

8.  Safety and Efficacy of Tien-Hsien Liquid Practical in Patients with Refractory Metastatic Breast Cancer: A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Phase IIa Trial.

Authors:  Wen-Hung Kuo; Chien-An Yao; Chih Hui Lin; King-Jen Chang
Journal:  Evid Based Complement Alternat Med       Date:  2012-04-01       Impact factor: 2.629

9.  Triterpenes from Poria cocos suppress growth and invasiveness of pancreatic cancer cells through the downregulation of MMP-7.

Authors:  Shujie Cheng; Isaac Eliaz; Junfang Lin; Anita Thyagarajan-Sahu; Daniel Sliva
Journal:  Int J Oncol       Date:  2013-04-16       Impact factor: 5.650

10.  Ultra performance liquid chromatography-based metabonomic study of therapeutic effect of the surface layer of Poria cocos on adenine-induced chronic kidney disease provides new insight into anti-fibrosis mechanism.

Authors:  Ying-Yong Zhao; Ya-Long Feng; Xu Bai; Xiao-Jie Tan; Rui-Chao Lin; Qibing Mei
Journal:  PLoS One       Date:  2013-03-26       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.